Saneca Pharmaceuticals has been acquired by AZC Group
AZC Group has acquired controlling ownership of Saneca Pharmaceuticals AS, a Slovakia-based pharmaceutical contract development and manufacturing organization (CDMO).
Saneca Pharmaceuticals is a Slovakia-based pharmaceutical CDMO focused on the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients (APIs). The company operates across the pharmaceutical value chain, offering end-to-end services from product development to commercial-scale manufacturing. It serves a diversified base of pharmaceutical companies, primarily in Europe, and produces over 1,300 SKUs across a broad range of dosage forms.
AZC is a diversified industrial group headquartered in Slovakia, operating across multiple sectors including biofuels, chemicals, agriculture, transport and logistics. The group manages a portfolio of industrial assets across several countries and integrates upstream and downstream activities within its businesses.
Oaklins’ team in Slovakia acted as the sole financial advisor to the seller.
Contacter l'équipe de la transaction
Transactions connexes
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
En apprendre plusMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
En apprendre plusQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
En apprendre plus